Results 71 to 80 of about 48,908 (228)

Population Pharmacokinetics of Ticagrelor during Veno‐Arterial ECMO in Acute Coronary Syndrome: Model‐Informed Dosing Simulations

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 193-202, July 2026.
Although patients with acute coronary syndrome supported by veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) have a high risk of thrombosis and bleeding, antiplatelet pharmacology in this setting is not well defined. This prospective observational study investigated the population pharmacokinetics of ticagrelor and its active metabolite AR ...
Soyoung Kang   +9 more
wiley   +1 more source

Rifabutin MIC distribution stratified among conventional rifampin-susceptible and rifampin-resistant isolates.

open access: yes, 2015
Conventional rifampin susceptible by APM (agar proportion method) critical concentration (MIC≤1.0 μg/ml) and resistance (MIC >1.0 μg/ml). Rifabutin critical concentration = 0.5 μg/ml; susceptible (2.0 μg/ml).
Jean Gratz (412093)   +9 more
core   +1 more source

Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant staphylococcus aureus colonization

open access: yes, 2007
Background. Eradication of methicillin-resistant Staphylococcus aureus (MRSA) carriage may reduce the risk of MRSA infection and prevent transmission of the organism to other patients. Methods.
Simor, A.E.   +6 more
core  

Mechanism of natural rifampin resistance of Streptomyces spp.

open access: yes, 2005
In a previous phylogenetic study of the genus Streptomyces using the rpoB gene, N531, which stands for an aspargine residue in position 531 of RpoB instead of serine (S531), known to be associated with natural rifampin resistance in several organisms ...
H Kim   +9 more
core   +1 more source

Vat Polymerization 3D Printing for Controlled Drug Release Applications

open access: yesAdvanced Materials Technologies, Volume 11, Issue 11, 5 June 2026.
ABSTRACT Vat polymerization (VP) 3D printing, a light‐based additive manufacturing technique, has emerged as a promising technique for fabricating complex drug delivery systems with high precision and spatial resolution. This layer‐by‐layer manufacturing process enables the creation of intricate geometries and customizable architectures, which are ...
Hafiz Busari   +2 more
wiley   +1 more source

New combination for patients with latent tuberculosis infection: A pilot study

open access: yesJournal of Medical Sciences, 2018
Background: Latent tuberculosis infection (LTBI) is characterized by the presence of immune responses to Mycobacterium tuberculosis without clinical evidence of active TB.
Te-Yu Lin, Feng-Cheng Liu
doaj   +1 more source

Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin

open access: yes, 1992
We examined the effect of azithromycin (CP-62,993), a new oral macrolide-like antibiotic, alone and in combination with rifampin, as treatment for experimental staphylococcal osteomyelitis. Clindamycin was used as a comparison drug.
Sande, E   +5 more
core   +1 more source

The Study of the Protective Effect of Black Cumin (Nigella sativa linn.)Ethanolic Extract Against Rifampin-induced Hepatotoxicity in Rats

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2015
Background and Objectives:Anti-tuberculosis drug, rifampin, is toxic for liver. This study was conducted to determine the preventive effects of black cumin (Nigella sativaLinn.) extract against rifampin-induced hepatotoxicity in rats. Methods: In this
Mehrdad Neshat Gharamaleki   +1 more
doaj  

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis

open access: yes, 2018
Yu-Tsung Huang,1–3 Chun-Hsing Liao,1,4 Shey-Ying Chen,5 Chia-Jui Yang,1,4 Hsin-Sui Hsu,1 Lee-Jene Teng,2,3 Po-Ren Hsueh2,6 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Department of Laboratory Medicine,
Hsueh PR   +6 more
core  

Regulation of MicroRNA Expression by Rifampin in Human Hepatocytes

open access: yes, 2013
Rifampin causes drug interactions by altering hepatic drug metabolism. Because microRNAs (miRNAs) have been shown to regulate genes involved in drug metabolism, we determined the effect of rifampin on the expression of hepatic miRNAs.
Philips, Santosh   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy